跳至主要内容
临床试验/NL-OMON56204
NL-OMON56204尚未招募不适用

The Effect of Furosemide on Protein-Bound Uremic Toxin Plasma Levels and Excretion in Patients with Chronic Kidney Disease - Furosemide-PBUT study

niversitair Medisch Centrum Utrecht0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • An age of 18 years or older
  • An eGFR <60 mL/min/1.73m2 for at least three months (diagnosis of CKD stage
  • An indication for the start of treatment with furosemide as part of routine
  • patient care
  • Willingness to participate in the study and a signed informed consent

排除标准

  • Patients who are already on furosemide treatment
  • Patients with a liver disease with hyperbilirubinemia
  • Patients who receive any type of renal replacement therapy (peritoneal
  • dialysis, haemodialysis)
  • Patients with end-stage renal failure without residual diuresis
  • Patients who will start with medication simultaneously with start of
  • furosemide treatment that might interfere with PBUT excretion or PBUT protein
  • Patients who are incapacitated

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验